Nav: Home

Low complication rates after screening colonoscopy

June 14, 2017

COLOGNE. During colonoscopy screening for bowel cancer and in the four weeks after the procedure, the risk for complications to develop is low. This is the finding of a prospective cohort study conducted in the Saarland region, whose results Nadine Zwink and coauthors report in the current issue of Deutsches Ärzteblatt International (Dtsch Aerztebl Int 2017; 114: 321-7).

Worldwide, bowel cancer is the most common cancer and the fourth most common cause of death in men and women. In Germany, colonoscopy screening as a service covered by the statutory health insurance schemes was introduced in October 2002. However, the associated routine documentation has registered only those complications that occurred immediately after the procedure (2.8/1000 colonoscopies). This may lead to an underestimation of the complications -- ie, perforations and bleeds/hemorrhages -- with delayed manifestation of symptoms.

In order to put a stop to the collection of such possibly unsatisfactory data, the authors from the German Cancer Research Center and from the Saarland cancer registry collected data in 26 practices of 5527 men (48%) and women (52%) who had undergone colonoscopy screening in 2010-13. They were asked to report on complications during and within 4 weeks after the colonoscopy at a follow-up examination, using a questionnaire. 5252 participants completed the questionnaire and were included in the study.

43 participants reported experiencing complications. However, only a small proportion of self-reported complications was confirmed medically; on the other hand, most of those affected were not aware of the bleeds/hemorrhages reported by their doctor. In total, 10 cases of bleeding/hemorrhage were confirmed by doctors, as were two cases of perforation during the colonoscopy, which in total equates to a medically confirmed complication rate of 20/5252=0.38%. Complications affected almost exclusively participants in whom neoplasms had been detected and removed.

For the authors, the study results showed that the complication rate is low, even when carefully considering a 4-week period after the colonoscopy. Especially in participants without colorectal neoplasms, who do not immediately benefit from colonoscopy screening, the rate of complications was found to be extremely low.

Deutsches Aerzteblatt International

Related Colonoscopy Articles:

Low complication rates after screening colonoscopy
During colonoscopy screening for bowel cancer and in the four weeks after the procedure, the risk for complications to develop is low.
Patients with positive fecal screening test, sooner is better for colonoscopy
The risk of colorectal cancer increased significantly when colonoscopy was delayed by more than nine months following a positive fecal screening test, according to a large Kaiser Permanente study published today in the Journal of the American Medical Association.
Delay in colonoscopy following positive screening test associated with increased risk of colorectal
Among patients with a positive fecal immunochemical test result, compared with follow-up colonoscopy at eight to 30 days, follow-up after 10 months was associated with a higher risk of colorectal cancer and more advanced-stage disease at the time of diagnosis, according to a study published by JAMA.
Colonoscopy prep may improve with some solid foods
There's good news for patients who dread the clear-liquid diet before a colonoscopy.
Knowledge of positive Cologuard test improves colonoscopy performance
An endoscopist's knowledge of a positive Cologuard test improves colonoscopy performance, according to a poster presentation at last week's Digestive Disease Week conference.
New Canadian recommendation against colonoscopy for routine screening of colorectal cancer
Physicians should screen for colorectal cancer in asymptomatic, low-risk adults aged 50 to 74 years every two years using fecal occult blood testing (FOBT), or flexible sigmoidoscopy every 10 years, rather than colonoscopy, according to a new Canadian guideline from the Canadian Task Force on Preventive Health Care in CMAJ (Canadian Medical Association Journal).
Virtual colonoscopy an alternative to FOB test & colonoscopy for colorectal cancer?
Colorectal cancer is the third most diagnosed cancer in the world, with population screening being recommended for early disease detection, however, the most optimal method to screen for the disease remains unknown.
Changing patient's position helps effectiveness of colonoscopy -- especially on one side
Having patients lie on their left side while the right side of their colon is being examined can result in more polyps being found, thus increasing the effectiveness of colonoscopy for colorectal cancer screening, according to a study in the September issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy.
Reference payment initiative for colonoscopy associated with lower prices, savings
The California Public Employees' Retirement System (CalPERS) saved $7 million on spending for colonoscopy two years after it implemented a reference payment initiative that offered full insurance coverage at low-priced facilities but required substantial cost sharing if patients picked a high-priced alternative, according to an article published online by JAMA Internal Medicine.
Cancers caught during screening colonoscopy are more survivable
Patients whose colorectal cancer is detected during a screening colonoscopy are likely to survive longer than those who wait until they have symptoms before having the test.

Related Colonoscopy Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#530 Why Aren't We Dead Yet?
We only notice our immune systems when they aren't working properly, or when they're under attack. How does our immune system understand what bits of us are us, and what bits are invading germs and viruses? How different are human immune systems from the immune systems of other creatures? And is the immune system so often the target of sketchy medical advice? Those questions and more, this week in our conversation with author Idan Ben-Barak about his book "Why Aren't We Dead Yet?: The Survivor’s Guide to the Immune System".